Alembic Pharma Archives - Express Pharma

Alembic Pharma announces U.S. FDA approval for Dabigatran Etexilate Capsules, 75 mg and 150 mg and tentative approval for Dabigatran Etexilate Capsules, 110 mg

Alembic Pharma announces USFDA final approval for Icatibant injection, 30 mg/3 mL (10 mg/mL) single-dose prefilled syringe

Alembic Pharma gets EIR from USFDA for its solid oral formulation facility at Jarod

USFDA gives tentative approval to Alembic Pharma’s acalabrutinib capsules, 100 mg

Alembic Pharma receives USFDA’s final approval for Fesoterodine Fumarate extended-release tablets

Alembic Pharma gets USFDA nod for Fulvestrant injection, 250 mg/5 mL per single-dose syringe

USFDA approves Alembic Pharma’s sANDA Pregabalin capsules

US FDA gives final approval to Alembic Pharma’s Desonide cream

US FDA gives final approval to Alembic Pharma’s Diclofenac Sodium Topical Solution

US FDA gives final approval to Alembic Pharma’s Nifedipine extended-release tablets